Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06871527 | Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer | not yet recruiting | Phase 1 / Phase 2 | 44 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06869694 | Energy CT in Imaging and Diagnosis of Gastric Cancer(CTIDGC) | recruiting | — | 300 | The First Affiliated Hospital of Zhengzhou UniversityOTHER |
| 1 |
| Mar 11, 2025 |
| clinicaltrials |
| NCT06773312 | BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. | recruiting | Phase 1 | 80 | Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 10, 2025 | clinicaltrials |
| NCT06858644 | Development of a Predictive Model for Gastric Cancer Peritoneal Metastasis and Cachexia Using BUB1 and Radiopathomics Data With Deep Learning(BUDDLE) | not yet recruiting | — | 500 | Qun ZhaoOTHER | 0 | Mar 5, 2025 | clinicaltrials |
| NCT01924819 | Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma(TOPGEAR) | active not recruiting | Phase 2 / Phase 3 | 574 | Australasian Gastro-Intestinal Trials GroupNETWORK | 10 | Mar 4, 2025 | clinicaltrials |
| NCT06856382 | The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer | active not recruiting | — | 20 | Dong PengOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT05165264 | A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer(INGA) | active not recruiting | — | 600 | Bristol-Myers SquibbINDUSTRY | 1 | Mar 3, 2025 | clinicaltrials |
| NCT06854146 | The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome | active not recruiting | — | 200 | Dong PengOTHER | 1 | Mar 3, 2025 | clinicaltrials |
| NCT04147078 | Personalized DC Vaccine for Postoperative Cancer | recruiting | Phase 1 | 80 | Sichuan UniversityOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT05319639 | Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab | recruiting | Phase 1 / Phase 2 | 51 | Fujian Cancer HospitalOTHER_GOV | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06421324 | Personalised Health Recommendations to the General Population Through an Integrated AI Guided(AIDA) | recruiting | N/A | 450 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06713421 | Effect of Premedication With Pronase on Mucosal Cleanliness During EGD | recruiting | N/A | 3,000 | Changhai HospitalOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT06839716 | Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic Gastrectomy | recruiting | N/A | 134 | Gangnam Severance HospitalOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT06841484 | Comparison of Full Robotic Instrumentation and Assistant-Controlled Laparoscopic Instrumentation in Robotic Distal Gastrectomy | recruiting | N/A | 36 | Gangnam Severance HospitalOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT06405113 | FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer | recruiting | Phase 2 | 198 | Changzhou No.2 People's HospitalOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT06289374 | Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery(LABS) | recruiting | — | 100 | Imperial College LondonOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT06778954 | Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy | recruiting | N/A | 48 | Gangnam Severance HospitalOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06055387 | Frailty Assessment and Intervention in Elderly Patients with Gastric Cancer Receiving Gastrectomy and Adjuvant Chemotherapy | recruiting | N/A | 300 | Chang Gung Memorial HospitalOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT05586061 | First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer(RCTS) | active not recruiting | Phase 2 | 55 | Qilu Hospital of Shandong UniversityOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT06782412 | Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types(FAPIDO) | recruiting | Phase 2 / Phase 3 | 109 | KU LeuvenOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT06814548 | Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study | not yet recruiting | — | 200 | Yongxu JiaOTHER | 0 | Feb 7, 2025 | clinicaltrials |
| NCT05033392 | PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer(PNACGEC) | recruiting | Phase 2 | 62 | Wan HeOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT05412758 | Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE) | recruiting | N/A | 648 | Imperial College LondonOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT06798376 | Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer | recruiting | — | 300 | Chinese PLA General HospitalOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT06306755 | Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer(ERSS-EGC) | recruiting | N/A | 21,000 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06790238 | POWER AUDIT, Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol After Gastric Surgery (POWER 4 + 3)(POWER 4 + 3) | active not recruiting | — | 350 | Grupo Español de Rehabilitación MultimodalOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06791083 | Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer | recruiting | Phase 2 | 40 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06791148 | Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer | recruiting | Phase 2 | 45 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06792162 | PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer | recruiting | Phase 2 | 20 | Peking University Third HospitalOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06786169 | The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer | recruiting | — | 600 | Fudan UniversityOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06787807 | Proteomic Analysis of Patients Undergoing Bariatric Surgery | not yet recruiting | N/A | 103 | Universidade Federal de PernambucoOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06785922 | Differences in Gastric Microbiota in Patients Who Were Infected Between CagA Positive and Negative Helicobacter Pylori | enrolling by invitation | N/A | 64 | Mahidol UniversityOTHER | 1 | Jan 21, 2025 | clinicaltrials |
| NCT06782048 | Use of Pyrvinium to Reverse Stomach Precancerous Conditions | not yet recruiting | Phase 2 | 50 | National University Hospital, SingaporeOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06776770 | A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer(GC-Ib/II) | recruiting | Phase 1 / Phase 2 | 52 | Cancer Hospital Chinese Academy of Medical Science, Shenzhen CenterOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT06776835 | Screening of Small Non-coding RNAs as an Auxiliary Diagnostic Biomarker for Gastric Cancer | enrolling by invitation | — | 300 | Affiliated Hospital of Nantong UniversityOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT06422403 | A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers(VALUE-CHECK) | recruiting | Phase 2 | 360 | National University Hospital, SingaporeOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06767436 | A Multi-center Real-world Efficacy and Safety of Trastuzumab-deruxtecan in Advanced Gastric Cancer | recruiting | — | 300 | Yonsei UniversityOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT06767449 | Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer(Zolbetuximab) | recruiting | — | 80 | Yonsei UniversityOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT04404595 | Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers | active not recruiting | Phase 1 / Phase 2 | 110 | CARsgen Therapeutics Co., Ltd.INDUSTRY | 2 | Jan 8, 2025 | clinicaltrials |
| NCT06690112 | Pilot Study for High Output Drainage Removal After Gastrectomy | recruiting | N/A | 60 | Gangnam Severance HospitalOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT03368963 | TAS102 in Combination With NAL-IRI in Advanced GI Cancers | active not recruiting | Phase 1 / Phase 2 | 64 | Emory UniversityOTHER | 1 | Jan 7, 2025 | clinicaltrials |
| NCT06760858 | A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer | recruiting | — | 122 | Southwest Hospital, ChinaOTHER | 1 | Jan 7, 2025 | clinicaltrials |
| NCT05344339 | Billroth-II Modified Versus Roux-en-Y After Distal Gastrectomy for Gastric Cancer | recruiting | N/A | 320 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Jan 1, 2025 | clinicaltrials |
| NCT06202105 | Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer(LOTA) | recruiting | N/A | 210 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Jan 1, 2025 | clinicaltrials |
| NCT04593615 | Indocyanine Green Tracer Using in Laparoscopic Radical Gastrectomy for Locally Advanced Gastric Cancer(CLASS-11) | active not recruiting | N/A | 1,070 | Fujian Medical UniversityOTHER | 1 | Dec 30, 2024 | clinicaltrials |
| NCT06054906 | Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer | recruiting | Phase 2 | 50 | Huashan HospitalOTHER | 1 | Dec 30, 2024 | clinicaltrials |
| NCT02112214 | Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population(HELPER) | active not recruiting | Phase 3 | 5,224 | National Cancer Center, KoreaOTHER_GOV | 1 | Dec 27, 2024 | clinicaltrials |
| NCT04214990 | Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients(EASTERN) | recruiting | Phase 3 | 1,700 | National Cancer Center, KoreaOTHER_GOV | 1 | Dec 27, 2024 | clinicaltrials |
| NCT04890171 | Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type(ERASE-GC) | recruiting | N/A | 708 | National Cancer Center, KoreaOTHER_GOV | 1 | Dec 27, 2024 | clinicaltrials |
| NCT06748352 | Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer | recruiting | N/A | 50 | Shandong UniversityOTHER | 1 | Dec 27, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Mar 12, 2025source: clinicaltrials